Jasper Therapeutics Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$0.63

+0.02 (+2.77%)

As of Sep 28, 10:32 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 9 75%

Hold 3 25%

Sell 0 0%

Price Target

Analyst Price Target +6,371.2% upside

Low Target $28.40

Average Target $40.51

High Target $50.89

Current Price $0.63

Current
$0.63

Target
$40.51

$28.40 $40.51 avg $50.89

Scenario Analysis

Bear Case

$28.40

4,436.7%

Low target

Base Case

$40.51

+6,371.2%

Avg target

Bull Case

$50.89

+8,029.4%

High target

Risk/Reward

1.8x

Balanced

Price in Context

52-Week High

$2.69

-76.7% from high

52-Week Low

$0.32

+98.7% from low

Target vs 52W High

$40.51

+1,405.9% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	39	82%	$257.58	-3.3%
AMGN Amgen Inc	Hold	43	47%	$190.87	-54.4%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+138.3%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	36	81%	$438.34	-16.9%
REGN Regeneron Pharmaceuticals	Buy	38	68%	$76.80	-89.8%
MRNA Moderna Inc	Hold	30	37%	$149.45	-24.2%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-65.3%
RVMD Revolution Medicines Inc	Strong Buy	28	93%	$114.11	-43.4%